{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:57Z","timestamp":1791389157684,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 2020JJ8111"],"award-info":[{"award-number":["No. 2020JJ8111"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO.82073893"],"award-info":[{"award-number":["NO.82073893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NO. 81472693"],"award-info":[{"award-number":["NO. 81472693"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prognostic factors and optimal treatment for the elderly patient with glioblastoma (GBM) were poorly understood. This study extracted 4975 elderly patients (\u2265\u200965\u00a0years old) with histologically confirmed GBM from Surveillance, Epidemiology and End Results (SEER) database. Firstly, Cumulative incidence function and cox proportional model were utilized to illustrate the interference of non-GBM related mortality in our cohort. Then, the Fine-Gray competing risk model was applied to determine the prognostic factors for GBM related mortality. Age\u2009\u2265\u200975\u00a0years old, white race, size\u2009&gt;\u20095.4\u00a0cm, frontal lobe tumor, and overlapping lesion were independently associated with more GBM related death, while Gross total resection (GTR) (HR 0.87, 95%CI 0.80\u20130.94, <jats:italic>P<\/jats:italic>\u2009=\u20090.010), radiotherapy (HR 0.64, 95%CI 0.55\u20130.74, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), chemotherapy (HR 0.72, 95%CI 0.59\u20130.90, <jats:italic>P<\/jats:italic>\u2009=\u20090.003), and chemoRT (HR 0.43, 95%CI 0.38\u20130.48, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) were identified as independently protective factors of GBM related death. Based on this, a corresponding nomogram was conducted to predict 3-, 6- and 12-month GBM related mortality, the C-index of which were 0.763, 0.718, and 0.694 respectively. The calibration curve showed that there was a good consistency between the predicted and the actual mortality probability. Concerning treatment options, GTR followed by chemoRT is suggested as optimal treatment. Radiotherapy and chemotherapy alone also provide moderate clinical benefits.<\/jats:p>","DOI":"10.1038\/s41598-021-88820-5","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T10:05:37Z","timestamp":1619690737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Competing risk model to determine the prognostic factors and treatment strategies for elderly patients with glioblastoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Zhuo-yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-shan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"88820_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"Q Ostrom","year":"2019","unstructured":"Ostrom, Q. et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol. 21, v1\u2013v100 (2019).","journal-title":"Neuro Oncol."},{"issue":"6","key":"88820_CR2","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/cam4.2754","volume":"9","author":"G Li","year":"2020","unstructured":"Li, G. et al. Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages. Cancer Med. 9(6), 1955\u20131965 (2020).","journal-title":"Cancer Med."},{"issue":"1","key":"88820_CR3","first-page":"48","volume":"30","author":"Y Xia","year":"2020","unstructured":"Xia, Y. et al. Nomograms for predicting the overall and cancer-specific survival of patients with high-grade glioma: a surveillance, epidemiology, and end results study. Turk. Neurosurg. 30(1), 48\u201359 (2020).","journal-title":"Turk. Neurosurg."},{"key":"88820_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fonc.2020.00151","volume":"10","author":"Q Han","year":"2020","unstructured":"Han, Q., Liang, H., Cheng, P., Yang, H. & Zhao, P. Gross total vs. subtotal resection on survival outcomes in elderly patients with high-grade glioma: a systematic review and meta-analysis. Front. Oncol. 10, 151 (2020).","journal-title":"Front. Oncol."},{"issue":"11","key":"88820_CR5","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/1078-0432.CCR-19-3359","volume":"26","author":"F Nassiri","year":"2020","unstructured":"Nassiri, F. et al. Determining the optimal adjuvant therapy for improving survival in elderly patients with glioblastoma: a systematic review and network meta-analysis. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 26(11), 2664\u20132672 (2020).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"88820_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11060-019-03375-w","volume":"146","author":"B Kalra","year":"2020","unstructured":"Kalra, B., Kannan, S. & Gupta, T. Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis. J. Neuro-oncol. 146(2), 311\u2013320 (2020).","journal-title":"J. Neuro-oncol."},{"key":"88820_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2015.08.010","volume":"70","author":"C van Walraven","year":"2016","unstructured":"van Walraven, C. & Hawken, S. Competing risk bias in Kaplan\u2013Meier risk estimates can be corrected. J. Clin. Epidemiol. 70, 101\u2013105 (2016).","journal-title":"J. Clin. Epidemiol."},{"issue":"9","key":"88820_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/bmt.2009.359","volume":"45","author":"L Scrucca","year":"2010","unstructured":"Scrucca, L., Santucci, A. & Aversa, F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transpl. 45(9), 1388\u20131395 (2010).","journal-title":"Bone Marrow Transpl."},{"issue":"446","key":"88820_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94(446), 496\u2013509 (1999).","journal-title":"J. Am. Stat. Assoc."},{"issue":"4","key":"88820_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","volume":"40","author":"L Scrucca","year":"2007","unstructured":"Scrucca, L., Santucci, A. & Aversa, F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transpl. 40(4), 381\u2013387 (2007).","journal-title":"Bone Marrow Transpl."},{"issue":"20","key":"88820_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.21037\/atm.2017.07.27","volume":"5","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Geskus, R. B., Kattan, M. W., Zhang, H. & Liu, T. Nomogram for survival analysis in the presence of competing risks. Ann. Transl. Med. 5(20), 403 (2017).","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"88820_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jgo.2019.10.013","volume":"11","author":"Y Ahmadipour","year":"2020","unstructured":"Ahmadipour, Y. et al. To resect or not to resect? Risks and benefits of surgery in older patients with glioblastoma. J. Geriatr. Oncol. 11(4), 688\u2013693 (2020).","journal-title":"J. Geriatr. Oncol."},{"issue":"9","key":"88820_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","volume":"4","author":"Q Ostrom","year":"2018","unstructured":"Ostrom, Q., Cote, D., Ascha, M., Kruchko, C. & Barnholtz-Sloan, J. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 4(9), 1254\u20131262 (2018).","journal-title":"JAMA Oncol."},{"issue":"8","key":"88820_CR14","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1002\/cam4.1688","volume":"7","author":"J Xie","year":"2018","unstructured":"Xie, J., Yang, S., Liu, X. & Zhao, Y. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status. Cancer Med. 7(8), 3722\u20133742 (2018).","journal-title":"Cancer Med."},{"issue":"1","key":"88820_CR15","doi-asserted-by":"publisher","first-page":"e0211513","DOI":"10.1371\/journal.pone.0211513","volume":"14","author":"S Liu","year":"2019","unstructured":"Liu, S., Liu, X., Xiao, Y., Chen, S. & Zhuang, W. Prognostic factors associated with survival in patients with anaplastic oligodendroglioma. PLoS ONE 14(1), e0211513 (2019).","journal-title":"PLoS ONE"},{"issue":"8","key":"88820_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/pon.773","volume":"13","author":"B Edwards","year":"2004","unstructured":"Edwards, B. & Clarke, V. The psychological impact of a cancer diagnosis on families: the influence of family functioning and patients\u2019 illness characteristics on depression and anxiety. Psychooncology 13(8), 562\u2013576 (2004).","journal-title":"Psychooncology"},{"issue":"6","key":"88820_CR17","first-page":"1","volume":"38","author":"M Tian","year":"2018","unstructured":"Tian, M. et al. Impact of gender on the survival of patients with glioblastoma. Biosci. Rep. 38(6), 1\u20139 (2018).","journal-title":"Biosci. Rep."},{"key":"88820_CR18","first-page":"1346340","volume":"2020","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Prognostic nomograms for primary high-grade glioma patients in adult: a retrospective study based on the SEER database. BioMed. Res. Int. 2020, 1346340 (2020).","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"88820_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3171\/2018.4.JNS18393","volume":"131","author":"G Puglisi","year":"2018","unstructured":"Puglisi, G. et al. Preserving executive functions in nondominant frontal lobe glioma surgery: an intraoperative tool. J. Neurosurg. 131(2), 474\u2013480 (2018).","journal-title":"J. Neurosurg."},{"issue":"1","key":"88820_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12885-019-6511-6","volume":"20","author":"J Liang","year":"2020","unstructured":"Liang, J. et al. Prognostic factors of patients with gliomas\u2014an analysis on 335 patients with glioblastoma and other forms of gliomas. BMC Cancer 20(1), 35 (2020).","journal-title":"BMC Cancer"},{"key":"88820_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clineuro.2014.11.006","volume":"128","author":"M Hoffermann","year":"2015","unstructured":"Hoffermann, M. et al. Treatment results and outcome in elderly patients with glioblastoma multiforme\u2013a retrospective single institution analysis. Clin. Neurol. Neurosurg. 128, 60\u201369 (2015).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"88820_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.wneu.2016.07.079","volume":"95","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Analysis of treatment tolerance and factors associated with overall survival in elderly patients with glioblastoma. World Neurosurg. 95, 77\u201384 (2016).","journal-title":"World Neurosurg."},{"issue":"6","key":"88820_CR23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/neuonc\/nou349","volume":"17","author":"SA Almenawer","year":"2015","unstructured":"Almenawer, S. A. et al. Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro Oncol. 17(6), 868\u2013881 (2015).","journal-title":"Neuro Oncol."},{"issue":"3","key":"88820_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11060-016-2331-6","volume":"131","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. J. Neuro-oncol. 131(3), 593\u2013601 (2017).","journal-title":"J. Neuro-oncol."},{"issue":"11","key":"88820_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"J Perry","year":"2017","unstructured":"Perry, J. et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N. Engl. J. Med. 376(11), 1027\u20131037 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"88820_CR26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert, F. et al. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med. 356(15), 1527\u20131535 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"88820_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick, W. et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 13(7), 707\u2013715 (2012).","journal-title":"Lancet Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88820-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:25:00Z","timestamp":1670052300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88820-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"25 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9321"}}